Yarbrough Capital’s QuidelOrtho QDEL Stock Holding History

Yarbrough Capital’s Portfolio QDEL Stock Details QDEL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-8,551	Closed	-$390K	–	208
2024 Q3	$390K	Hold	8,551	–	–	0.02%	159
2024 Q2	$284K	Hold	8,551	–	–	0.01%	175
2024 Q1	$410K	Hold	8,551	–	–	0.02%	151
2023 Q4	$630K	Hold	8,551	–	–	0.03%	114
2023 Q3	$625K	Hold	8,551	–	–	0.04%	110
2023 Q2	$709K	Hold	8,551	–	–	0.04%	110
2023 Q1	$762K	Buy	+8,551	New	+$744K	0.06%	99

Other funds holding QDEL

T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

RCMNY

Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

ACH

ArrowMark Colorado Holdings Denver, Colorado $2.4B AUM 42.85% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Yarbrough Capital's QDEL Position: Q4 2024 in Review

Yarbrough Capital sold out of QuidelOrtho (QDEL) in Q4 2024, closing a stake of 8,551 shares — an estimated $390K sold.

Yarbrough Capital first reported a position in QDEL in Q1 2023 and held it in 7 quarters. The position peaked at $762K in Q1 2023. 275 funds tracked by Wall St. Rank hold QDEL as of Q4 2024.

Yarbrough Capital reported no remaining QuidelOrtho position as of Q4 2024 after selling out during the quarter.
Yarbrough Capital sold 8,551 QuidelOrtho shares in Q4 2024, an estimated $390K.
Yarbrough Capital first reported a position in QuidelOrtho in Q1 2023 and held it in 7 quarters.
Yarbrough Capital's QuidelOrtho position peaked at $762K in Q1 2023.
275 funds tracked by Wall St. Rank held QuidelOrtho as of Q4 2024.

Based on Yarbrough Capital's 13F filing for Q4 2024, filed 15 Jan 2025.